Johnson & Johnson Partners with Sail Biomedicines to Advance In Vivo CAR-T Therapies for Immune-Mediated Diseases Johnson & Johnson has announced a broad strategic collaboration with Sail Biomedicines, a biotechnology company pioneering the development of in vivo chimeric antigen receptor…
VDyne Launches Pivotal TRIVITA Study, Treats First Patient with TriNova™ Transcatheter Tricuspid Valve Replacement System VDyne Inc., a privately held medical device company focused on advancing structural heart therapies, has reached an important milestone in the development of its innovative…
Vergent Bioscience Reports Promising Phase 2B Results for Abenacianine, Advancing Real-Time Tumor Imaging During Lung Cancer Surgery Vergent Bioscience, a clinical-stage biotechnology company focused on developing innovative tumor-targeted imaging technologies, has announced the publication of encouraging clinical data supporting its…
Secretome Therapeutics Strengthens Executive Leadership Team to Advance Rare Disease Pipeline and Regenerative Medicine Platform Secretome Therapeutics, a clinical-stage biotechnology company developing regenerative therapies derived from neonatal cardiac progenitor cells (nCPCs), has announced a significant expansion of its executive leadership…
Glaukos Completes Enrollment in Pivotal U.S. Study of PRESERFLO™ MicroShunt for Advanced Primary Open-Angle Glaucoma Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company dedicated to developing innovative treatments for glaucoma, corneal disorders, and retinal diseases, has announced the successful…
GCCL and GemPharmatech Form Strategic Alliance to Deliver Integrated Drug Discovery and Clinical Development Solutions GCCL, a South Korea-based provider of clinical trial sample analysis and central laboratory services, and GemPharmatech, a global leader in genetically engineered animal models and…
Arrowhead Pharmaceuticals Reports Positive Phase 3 Results for Plozasiran in Severe Hypertriglyceridemia, Demonstrating Significant Triglyceride Reduction and Lower Risk of Acute Pancreatitis Arrowhead Pharmaceuticals, Inc. has announced positive topline results from its pivotal global Phase 3 SHASTA-3 and SHASTA-4 clinical…
Johnson & Johnson Receives FDA De Novo Authorization for OTTAVA™ Robotic Surgical System, Marking a New Era in Robotic-Assisted Surgery Johnson & Johnson has achieved a major milestone in the field of surgical innovation after the U.S. Food and Drug…
Seek Labs Publishes Nature Communications Study Showcasing ANINA™ Technology for Next-Generation Molecular Diagnostics Seek Labs, a private TechBio company focused on developing programmable technologies to decode, understand, and treat disease, has announced the publication of a peer-reviewed research paper in…
Restore Vision and Forge Biologics Partner to Advance RV-001 Gene Therapy for Retinitis Pigmentosa Through Clinical Development Restore Vision, Inc., a clinical-stage biotechnology company focused on developing innovative gene therapies for retinal diseases, has announced a strategic development and manufacturing…
Brenus Pharma Secures €11 Million Series A Extension to Advance Lead Cancer Immunotherapy and Expand Proprietary In Vivo Immunotherapy Platform Brenus Pharma has announced the successful completion of an €11 million ($12.6 million) extension to its Series A financing round,…
DivcoWest Announces Collegium Pharmaceutical as One Lincoln Tenant DivcoWest, a DivCore Capital company and a leading national commercial real estate investment firm, has announced that Collegium Pharmaceutical, a biopharmaceutical company focused on developing innovative medicines for central nervous system (CNS)…